answer text |
<p>Given the very high risk of exposure to infection and outbreaks in residential
settings, the Joint Committee on Vaccination and Immunisation (JCVI) advises that
COVID-19 vaccination may be considered for children with severe neuro-disabilities
with recurrent respiratory tract infections and who frequently spend time in specialised
residential care settings for children with complex needs.</p><p>The JCVI’s advice
is that clinicians should discuss the risks and benefits of vaccination with a person
with parental responsibility, who should be told about the position on safety data
for the vaccine in children aged under 16 years old. However, the matter of whether
to offer vaccination to an individual, whether a child or adult, will ultimately be
a decision for the physician responsible for the patient. The JCVI’s advice to the
Government is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020/joint-committee-on-vaccination-and-immunisation-advice-on-priority-groups-for-covid-19-vaccination-30-december-2020"
target="_blank">https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020/joint-committee-on-vaccination-and-immunisation-advice-on-priority-groups-for-covid-19-vaccination-30-december-2020</a></p>
|
|